Scedosporium apiospermum disseminated infection in a single lung transplant recipient;Infección diseminada por Scedosporium apiospermum en un receptor de trasplante pulmonar unilateral

Revista Iberoamericana de Micologia

Volumn 28, Issue 3, 2011, Pages 139-142

  Solé, Amparo ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Lung transplant; Scedosporium apiospermum; Scedosporium prolificans; Voriconazole

Indexed keywords

AMPHOTERICIN B; VORICONAZOLE;

ARTICLE; CHRONIC GRAFT REJECTION; FUNGAL COLONIZATION; GRAFT RECIPIENT; HUMAN; INFECTION PREVENTION; LUNG FIBROSIS; LUNG TRANSPLANTATION; MOULD; MYCETOMA; PSEUDALLESCHERIASIS; RISK FACTOR; SCEDOSPORIUM APIOSPERMUM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS; COMBINED MODALITY THERAPY; CROSS INFECTION; DEBRIDEMENT; DEOXYCHOLIC ACID; DRUG COMBINATIONS; FATAL OUTCOME; FUNGEMIA; GRAFT REJECTION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; ITRACONAZOLE; KETOCONAZOLE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCETOMA; OPPORTUNISTIC INFECTIONS; POSTOPERATIVE COMPLICATIONS; SCEDOSPORIUM;

FUNGI; PSEUDALLESCHERIA BOYDII; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS;

EID: 79959342211     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2011.06.007     Document Type: Article

References (21)

1. Alastruey-Izquierdo A., Cuenca-Estrella M., Monzon A., Rodriguez-Tudela J.L. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob Agents Chemother. 2007, 51:748-751.
2. Castiglioni B., Sutton D.A., Rinaldi M.G., FungJ, Kusne S. Clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother. 2000, 44:470-472.
3. Chambers DC, Solé A. Mold infections in cardiothoracic transplantation. En: Moo-ney, M., Hannan, M.M., Husain, S., editors. Diagnosis and management of infections diseases in cardiothoracic transplantation and mechanical support. Vol. 5 New York: ISHLT;2011. p. 195-209.
4. Cortez K.J., Roilides E., Quiroz-Telles F., Meletiadis J., Antachopoulos C., Knudsen T., et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008, 21:157-197.
5. Cuenca-Estrella M., Alastruey-Izquierdo A., Alcazar-Fuoli L., Bernal-Martinez L., Gomez-Lopez A., Buitrago M.J., et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother. 2008, 52:1136-1139.
6. Gilgado F., Cano J., Gene J., Serena C., Guarro J. Different virulence of 267 the species of the Pseudallescheria boydii complex. Med Mycol. 2008, 47:371-374.
7. Girmenia C., Luzi G., Monaco M., Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol. 1998, 36:1436-1438.
8. Howden B.P., Slavin M.A., Schwarer A.P., Mijch A.M. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbina-fine. Eur J Clin Microbiol Infect Dis. 2003, 22:111-113.
9. Husain S., Munoz R., Forrest G., Alexander B.D., Somani J., Brennan K., et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005, 40:89-99.
10. Meletiadis J., Mouton J.W., MeisJF, Verweij P.E. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 2003, 47:106-117.
11. Meletiadis J., Mouton J.W., Rodriguez-TudelaJL, MeisJF, Verweij P.E. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother. 2000, 44:470-472.
12. Montoya J.G., Rosso F. Is combination therapy indicated for invasive fungal infections?. Yes and no. Curr Opin Infect Dis. 2006, 19:357-359.
13. Morio F., Horeau-Langlard D., Gay-Andrieu F., Talarmin J.P., Haloun A., Treilhaud M., et al. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol. 2010, 48:1978-1982.
14. Musk M., Chambers D., Chin W., Murray R., Gabbay E. Successful treatment of disseminated Scedosporium infection in 2 lung transplant recipients: Review of the literature and recommendations for management. J Heart Lung Transplant. 2006, 25:1269-1272.
15. Sahi H., Avery R.K., Minai O.A., Hall G., Metha A.C., Raina P., et al. Scedosporium apios-permum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant. 2007, 26:350-356.
16. Silveira F.P., Kwak E.J., Paterson D.L., Pilewski J.M., McCurry K.R., Husain S. Post-transplant colonization with non-Aspergillus molds and risk of development of inva-sive fungal disease in lung transplant recipients. J Heart Lung Transplant. 2008, 27:850-855.
17. Solé A., Salavert M. Fungal infections after lung transplantation. Curr Opin Pulm Med. 2009, 15:243-253.
18. Solé A., Salavert M. Fungal infections after lung transplantation. Transplant Rev. 2008, 22:89-104.
19. Solé A., Salavert M. Voriconazol como terapia de las micosis en receptores de tras-plantes de órganos sólidos. Rev Iberoam Micol. 2007, 24:217-222.
20. Symoens F., Knoop C., Schrooyen M., Denis O., Estenne M., Nolard N., et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant. 2006, 25:603-607.
21. Troke P., Aguirrebengoa K., Arteaga C., Ellis D., Heath C.H., Lutsar I., et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimi-crob Agents Chemother. 2008, 52:1743-1750.